Open access peer-reviewed chapter

Risk Factors in the Patients with Extracranial Carotid Atherosclerosis

Written By

Mei-Ling Sharon Tai, Julia Sien Yuin Liew, Sheun Yu Mo and Mohamed Abdusalam Elwaifa

Submitted: 27 November 2017 Reviewed: 22 February 2018 Published: 17 October 2018

DOI: 10.5772/intechopen.75808

From the Edited Volume

Peripheral Arterial Disease - A Practical Approach

Edited by Nishtha Sareen and Abhishek Ojha

Chapter metrics overview

1,112 Chapter Downloads

View Full Metrics

Abstract

There are vascular risk factors known to be associated with stroke. These risk factors have been shown to either directly or indirectly lead to stroke. The risk factors include hypertension (HT), diabetes mellitus (DM), smoking, hyperlipidaemia, ischemic heart disease (IHD) and atrial fibrillation (AF). Studies have shown that carotid atherosclerosis is a cause of stroke. Extracranial carotid atherosclerosis accounts for up to 40% of the ischemic strokes in the Western countries. The latest stroke guidelines recommend the routine use of Ultrasound Carotid Doppler to assess for extracranial carotid artery atherosclerotic diseases (carotid intima media thickness, plaques, carotid stenosis) in these patients. A previous study emphasized the value of carotid ultrasonography in the detection of early extracranial carotid atherosclerosis.

Keywords

  • extracranial
  • carotid
  • atherosclerosis
  • risk
  • factors

1. Introduction

Stroke is one of the most common diseases in the world and results in up to 10% of mortality globally [1]. Stroke is the third leading cause of mortality and long-term disability in the United States of America [2].

There are vascular risk factors known to be associated with ischemic strokes [3]. These risk factors have been shown to either directly or indirectly lead to stroke [3]. The risk factors include hypertension (HT), diabetes mellitus (DM), smoking, hyperlipidaemia, ischemic heart disease (IHD) and atrial fibrillation (AF) [3].

Studies have shown that carotid atherosclerosis is a cause of stroke [4]. Annually, about 20–30% of new strokes are due to atherosclerotic carotid artery disease [5]. The latest stroke guidelines recommend the routine use of ultrasound carotid Doppler to assess for extracranial carotid artery atherosclerotic diseases (carotid intima media thickness, plaques, carotid stenosis) in these patients [6].

Ultrasound carotid Doppler is a non-invasive and cost-effective test [7]. Carotid intima media thickness (CIMT) measurements and plaque location are evaluated on gray scale imaging (B-mode) [7]. Flow disturbance and stenosis is assessed on color Doppler [7]. The blood flow velocities are examined on spectral Doppler [7].

A previous study emphasized the value of ultrasound carotid Doppler in the detection of early extracranial carotid atherosclerosis [4]. In the world, an increased CIMT is found in 9.4% of the men and 11.7% of the women [4]. Assessment of CIMT increases with ultrasound carotid Doppler in the subjects without carotid atherosclerosis and free of previous vascular events predicts the occurrence of carotid plaque [8].

The prevalence of carotid plaque is 13.3% in the men and 13.4% in the women in the world [8]. The prevalence of extracranial carotid stenosis is 2.7% in the men and 1.5% in the women globally [8]. Stroke is associated with the plaques containing softer tissue, especially with thin fibrous cap [2].

Hyperlipidaemia is a common risk factor for extracranial atherosclerosis [9]. The risk factor of hyperlipidaemia was one of the two most common risk factors for stroke in Singapore (76.5–86.4%) [3]. Hyperlipidaemia results in an atheroma or a fibrofatty plaque leading to gradual occlusion of the arteries. As the plaques increase in size, they progressively occlude the lumen and compromise the blood flow causing stroke [10]. In the South Korean studies, extracranial atherosclerosis was associated with higher LDL levels [9, 11].

Furthermore, low levels of HDL cholesterol are associated with an increased risk of having echolucent, rupture-prone atherosclerotic plaques [12]. In addition, an increased risk of having an echolucent plaque is independently associated with increasing degree of stenosis [12]. The subjects with echolucent plaques have increased risk of ischemic cerebrovascular events and stroke independent of the degree of stenosis and cardiovascular risk factors [13].

A community-based study in Taiwan showed that hypertension strongly influenced extracranial carotid atherosclerosis and hypertension was the predictor of carotid stenosis ≥50% [14, 15]. The frequencies of hypertension among the stroke patients in the other Asian countries were: 59% in Pakistan [16], 38.3% in Japan [17], and 19–28% in China, Korea and Taiwan [17].

There are several mechanisms of stroke due to hypertension. High blood pressure results in endothelial damage, which leads to thrombi formation [18]. Hypertension is also known to accelerate the atherosclerotic process [18]. Moreover, in the general population, hypertension is a predictor of the occurrence of plaques [8]. Systolic blood pressure is significantly associated with severe extracranial carotid atherosclerosis (plaque, stenosis) [4].

The percentages of ischemic stroke patients with DM were 37% in Pakistan [16] and 30% in South Korea [11]. DM is an important risk factor for extracranial carotid atherosclerosis [14, 19]. DM affects the vascular endothelium and reduces the bioavailability of nitric oxide (NO), which is a major anti-atherosclerotic agent [20, 21, 22]. Hyperglycemia inhibits the production of NO by restraining the activation of endothelial NO synthase [23]. In addition, the prevalence of extracranial carotid atherosclerosis is significantly higher in the ketosis-onset DM patients than in the control subjects [24]. The frequency of extracranial carotid atherosclerosis in the ketosis-onset DM patients is similar to the non-ketotic type 2 DM patients [24].

Smoking is also known to be associated with atherosclerosis of the extracranial carotid vessels [14]. The percentage of the patients with smoking history was 25% in Wasay et al.’s study [16]. Smoking leads to damage of cells that line the arteries. In addition, smoking increases the build-up of plaque constituents in the arteries. Moreover, smoking results in thickening and narrowing of the arteries [25].

Smoking history is a determinant of the occurrence of a new carotid plaque in the subjects with no previous carotid atherosclerosis and also free of previous vascular events [8]. In addition, there is a significant association between severe extracranial carotid atherosclerosis and smoking [4]. Furthermore, smoking was found to be associated with carotid plaque and extracranial carotid stenosis in several studies [9, 26, 27]. Cessation of smoking will be helpful in the management of these stroke patients.

IHD and ischemic stroke are vascular diseases [28]. IHD was present in 11.8–20% of the Singapore stroke patients [3]. Moreover, IHD was associated with carotid stenosis in a study [27]. In another study conducted in Japan on consecutive patients who had coronary angiography, 6% of them had extracranial carotid stenosis [29].

AF is known cardiovascular risk factor of stroke [30]. AF can predispose to embolism and stroke [31]. AF is commonly associated with stroke in South Asia, Western Europe, North America and Australia [32]. Increased CIMT and presence of carotid plaque are associated with increased risk of ischemic stroke in the patients with AF [33]. Higher CIMT and the presence of carotid plaque are associated with higher incidence of AF incidence [34].

Age is an important risk factor for extracranial carotid atherosclerosis, especially in the Chinese and South Koreans [9, 11, 14, 19, 35]. These patients tend to be older in age [9, 11, 19, 35]. Age is a significant predictor of the occurrence of a new carotid plaque in the general population [8]. The incremental probability of the occurrence of plaque is higher in the subject’s midlife [8]. In the subjects aged ≥40 years old, the severity of carotid atherosclerosis (plaques, stenosis) was significantly associated with age [4]. Moreover, the frequency of extracranial carotid atherosclerosis significantly increases with age in the DM patients (ketosis-onset and non-ketotic DM) [24].

Male gender is also risk factor for extracranial atherosclerosis [9, 19]. 14.8% of the patients with extracranial atherosclerosis, had family history of stroke [9]. In a Chinese study, 48.4% of the healthy population with extracranial carotid atherosclerosis had obesity [19].

Elevated CIMT is associated with an increased risk of stroke [20]. Plaque rupture with subsequent embolism can lead to stroke [20]. The presence of plaque is associated with an increased risk morbidity and mortality secondary to stroke [28].

One population study showed the relationship between extracranial carotid atherosclerotic lesions with the classic risk factors such hypertension, hyperlipidaemia and smoking [28]. An European Rotterdam Elderly Study showed that hypertension, smoking and reduced serum HDL were associated with carotid artery stenosis [36]. In that study, factor VIIc and factor VIIIc (hemostatic factor) activity was higher in the patients with extracranial carotid disease [36].

Altogether, the number of classic risk factors among the patients with extracranial atherosclerosis was 1.67 in a South Korean study [11]. The number of traditional risk factors in the patients with severe extracranial atherosclerosis was almost similar (1.68) [11].

CIMT is a marker of subclinical atherosclerosis and hypertension has been known to be risk factor of atherosclerosis [28]. Therefore, proper monitoring of CIMT and treatment can potentially be helpful to these patients to prevent further progression to plaques and stenosis. In a previous study, 18.2% of the patients with extracranial atherosclerosis had history of previous stroke [11]. Among the patients with severe extracranial atherosclerosis, 21.6% of them had history of previous stroke [11].

Furthermore, a study by Amarenco et al. showed that there was a higher prevalence of coronary plaques, with concomitant carotid plaques, in patients with non-fatal ischemic stroke with no known IHD [37]. In a study done among Chinese patients, 7.8% of the patients with paroxysmal AF had a combination of extracranial carotid stenosis and IHD [30].

The miR-146a rs2910164 polymorphism may be associated with carotid vulnerable plaque risk in the Chinese patients with type 2 DM, particularly in older patients and women [38]. This polymorphism may be associated with carotid vulnerable plaque risk in the patients with DM duration of >10 years and the patients with hypertension [38].

In addition, the metabolically abnormal but normal weight subjects have increased CIMT compared to the metabolically healthy but obese subjects and metabolically healthy normal weight subjects [39]. The patients with extracranial carotid atherosclerosis are more likely to have contralateral extracranial carotid atherosclerosis [26].

In terms of ethnic variation, the South Asians have the higher prevalence of extracranial carotid atherosclerosis compared to the Europeans and Chinese [20]. The South Asians have an increased frequency of impaired glucose tolerance, hypercholesterolemia (higher total and LDL cholesterol), hypertriglyceridemia and lower HDL cholesterol [20]. In addition, the South Asians have higher concentrations of fibrinogen, homocysteine, lipoprotein (a), and plasminogen activator inhibitor-1 [20].

The Chinese have lower rates of cardiovascular disease than the Europeans [40]. Furthermore, the Chinese have a more favorable risk factor profile except for impaired glucose tolerance [40]. The Europeans are more likely to be current or former smokers [20]. The Caucasians with severe extracranial carotid stenosis are more obese than those without such stenosis, unlike the Japanese [41].

In conclusion, proper identification and optimization of the risk factors in the patients with extracranial carotid atherosclerosis in important. This will help to prevent or slow down the progression of the extracranial carotid atherosclerosis. By preventing the development of carotid stenosis, the occurrence of ischemic stroke can be minimized (Figure 1 and Table 1).

Figure 1.

Diagram showing plaques at the carotid bulb extending to the internal carotid artery [2].

1. Hypertension
2. Diabetes mellitus
3. Hyperlipidaemia
4. Smoking
5. Ischemic heart disease
6. Atrial fibrillation
7. Advancing age
8. Male gender
9. miR-146a rs2910164 polymorphism
10. Metabolically abnormal but normal weight

Table 1.

Risk factors of extracranial carotid atherosclerosis [9, 14, 18, 19, 28, 30, 38, 39].

References

  1. 1. Santulli G. Epidemiology of cardiovascular disease in the 21st century: Updated numbers and updated facts. Journal of Cardiovascular Disease. 2013;1:1-2
  2. 2. Allen JD, Ham KL, Dumont DM, Sileshi B, Trahey GE, Dahl JJ. The development and potential of acoustic radiation force impulse (ARFI) imaging for carotid artery plaque characterization. Vascular Medicine. 2011 Aug;16(4):302-311
  3. 3. Sharma VK, Tsivgoulis G, Teoh HL, Ong BK, Chan BP. Stroke risk factors and outcomes among various Asian ethnic groups in Singapore. Journal of Stroke and Cerebrovascular Diseases. 2012 May;21(4):299-304
  4. 4. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi F, Feruglio GA, Touboul PJ. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992 Dec;23(12):1705-1711
  5. 5. Timsit S, Sacco R, Mohr J, Foulkes M, Tatemichi T, Wolf P, Price T, Hier D. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke. 2007;23:486-491
  6. 6. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, Cates CU, Creager MA, Fowler SB, Friday G, Hertzberg VS, McIff EB, Moore WS, Panagos PD, Riles TS, Rosenwasser RH, Taylor AJ. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SC’AI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, society of NeuroInterventional surgery, Society for Vascular Medicine, and society for vascular surgery. Stroke. 2011;42:e420-e463
  7. 7. Gaitini D, Soudack M. Diagnosing carotid stenosis by Doppler sonography: State of the art. Journal of Ultrasound in Medicine. 2005 Aug;24(8):1127-1136
  8. 8. Prati P, Vanuzzo D, Casaroli M, Bader G, Mos L, Pilotto L, Canciani L, Ruscio M, Touboul PJ. Determinants of carotid plaque occurrence. A long-term prospective population study: The san Daniele project. Cerebrovascular Diseases. 2006;22(5-6):416-422
  9. 9. Kim JS, Nah HW, Park SM, Kim SK, Cho KH, Lee J, Lee YS, Kim J, Ha SW, Kim EG, Kim DE, Kang DW, Kwon SU, Yu KH, Lee BC. Risk factors and stroke mechanisms in atherosclerotic stroke: Intracranial compared with extracranial and anterior compared with posterior circulation disease. Stroke. 2012 Dec;43(12):3313-3318
  10. 10. Khan MRK. Hyperlipidemia as a Risk Factor for Ischaemic Stroke. www.orion-group.net/journals/Journals/vol19_Sept2004/199.htm
  11. 11. Kim YD, Choi HY, Jung YH, Nam CM, Yang JH, Cho HJ, Nam HS, Lee KY, Heo JH. Classic risk factors for atherosclerosis are not major determinants for location of extracranial or intracranial cerebral atherosclerosis. Neuroepidemiology. 2009;32(3):201-207
  12. 12. Mathiesen EB, Bønaa KH, Joakimsen O. Low levels of high-density lipoprotein cholesterol are associated with echolucent carotid artery plaques: The tromsø study. Stroke. 2001 Sep;32(9):1960-1965
  13. 13. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: The tromsø study. Circulation. 2001 May 1;103(17):2171-2175
  14. 14. Liu CY, Chen CQ. Intra- and extracranial atherosclerotic stenosis in China: Epidemiology, diagnosis, treatment and risk factors. European Review for Medical and Pharmacological Sciences. 2014 Nov;18(22):3368-3379
  15. 15. Su TC, Jeng JS, Chien KL, Sung FC, Hsu HC, Lee YT. Hypertension status is the major determinant of carotid atherosclerosis: A community-based study in Taiwan. Stroke. 2001;32:2265-2271
  16. 16. Wasay M, Azeemuddin M, Masroor I, Sajjad Z, Ahmed R, Khealani BA, Malik MA, Afridi MB, Kamal A. Frequency and outcome of carotid atheromatous disease in patients with stroke in Pakistan. Stroke. 2009 Mar;40(3):708-712
  17. 17. Kim YD, Jung YH, Saposnik G. Traditional risk factors for stroke in East Asia. Journal of Stroke. 2016 Sep;18(3):273-285
  18. 18. Johansson BB. Hypertension mechanisms causing stroke. Clinical and Experimental Pharmacology & Physiology. 1999 Jul;26(7):563-565
  19. 19. Pan XF, Lai YX, Gu JQ, Wang HY, Liu AH, Shan ZY. Factors significantly associated with the increased prevalence of carotid atherosclerosis in a northeast Chinese middle-aged and elderly population: A cross-sectional study. Medicine (Baltimore). 2016 Apr;95(14):e3253
  20. 20. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The study of health assessment and risk in ethnic groups (SHARE). Lancet. 2000 Jul 22;356(9226):279-284
  21. 21. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. Journal of the American Medical Association. 2002;287:2570-2581
  22. 22. Lloyd-Jones DM, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annual Review of Medicine. 1996;47:365-375
  23. 23. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. British Journal of Pharmacology 2000;130:963-974
  24. 24. Li LX, Zhao CC, Ren Y, Tu YF, Lu JX, Wu X, Zhang WX, Zhu JA, Li MF, Yu LB, Bao YQ, Jia WP. Prevalence and clinical characteristics of carotid atherosclerosis in newly diagnosed patients with ketosis-onset diabetes: A cross-sectional study. Cardiovascular Diabetology. 2013 Jan 16;12:18
  25. 25. Centre for Disease Control and Prevention (CDC)-Health Effects-Heart Disease-Smoking &TobaccoUse. http://www.cdc.gov/tobacco/basic_information/health_effects/heart_disease/
  26. 26. Chen H, Hong H, Xing S, Liu G, Zhang A, Tan S, Zhang J, Zeng J. Intracranial versus Extracranial symptomatic carotid atherosclerosis in Chinese patients: Risk factors, stroke mechanisms, and long-term prognosis. Journal of Stroke and Cerebrovascular Diseases. 2015 Nov;24(11):2632-2639
  27. 27. Leung SY, Ng TH, Yuen ST, Lauder IJ, Ho FC. Pattern of cerebral atherosclerosis in Hong Kong Chinese. Severity in intracranial and extracranial vessels. Stroke. 1993 Jun;24(6):779-786
  28. 28. Keo HH, Baumgartner, Hirsch AT, Duval S, Steg PG, Pasquet B, Bhatt DL, Roether J, REACH Registry Investigators. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease. Vascular Medicine. 2011 Oct;16(5):323-330
  29. 29. Tanimoto S, Ikari Y, Tanabe K, Yachi S, Nakajima H, Nakayama T, Hatori M, Nakazawa G, Onuma Y, Higashikuni Y, Yamamoto H, Tooda E, Hara K. Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population. Stroke. 2005 Oct;36(10):2094-2098
  30. 30. Gu Y, Feng L, Xu Y, Zhao Y. Co-prevalence of carotid stenosis and coronary artery disease in Chinese patients with paroxysmal atrial fibrillation. The Journal of International Medical Research. 2014 Dec;42(6):1294-1300
  31. 31. Chee KH, Tan KS. Impact of atrial fibrillation among stroke patients in a Malaysian teaching hospital. The Medical Journal of Malaysia. 2014 Jun;69(3):119-123
  32. 32. O' Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016 Aug 20;388(10046):761-775
  33. 33. Bekwelem W, Jensen PN, Norby FL, Soliman EZ, Agarwal SK, Lip GY, Pan W, Folsom AR, Longstreth WT Jr, Alonso A, Heckbert SR, Chen LY. Carotid atherosclerosis and stroke in Atrial fibrillation: The atherosclerosis risk in communities study. Stroke. 2016 Jun;47(6):1643-1646
  34. 34. Chen LY, Leening MJ, Norby FL, Roetker NS, Hofman A, Franco OH, Pan W, Polak JF, Witteman JC, Kronmal RA, Folsom AR, Nazarian S, Stricker BH, Heckbert SR, Alonso A. Carotid Intima-media thickness and arterial stiffness and the risk of Atrial fibrillation: The atherosclerosis risk in communities (ARIC) study, multi-ethnic study of atherosclerosis (MESA), and the Rotterdam study. Journal of the American Heart Association. 2016 May;20:5(5)
  35. 35. Li D, Wang ML, Li SM, Ling F. Distribution and risk factors of steno-occlusive lesions in patients with ischemic cerebrovascular disease. Zhonghua Yi Xue Za Zhi. 2008;88:1158-1162
  36. 36. Bots ML, Breslau PJ, Briët E, de Bruyn AM, van Vliet HH, van den Ouweland FA, de Jong PT, Hofman A, Grobbee DE. Cardiovascular determinants of carotid artery disease. The Rotterdam Elderly Study. Hypertension. 1992 Jun; 19(6 Pt 2):717-720
  37. 37. Amarenco P, Lavallée PC, Labreuche J, Ducrocq G, Juliard JM, Feldman L, Cabrejo L, Meseguer E, Guidoux C, Adraï V, Ratani S, Kusmierek J, Lapergue B, Klein IF, Gongora-Rivera F, Jaramillo A, Mazighi M, Touboul PJ, Steg PG. Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke. 2011 Jan;42(1):22-29
  38. 38. Shen J, Zhang M, Sun M, Tang K, Zhou B. The relationship of miR-146a gene polymorphism with carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus. Thrombosis Research. 2015 Dec;136(6):1149-1155
  39. 39. Yoo HJ, Hwang SY, Hong HC, Choi HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM. Association of metabolically abnormal but normal weight (MANW) and metabolically healthy but obese (MHO) individuals with arterial stiffness and carotid atherosclerosis. Atherosclerosis. 2014 May;234(1):218-223
  40. 40. Harland J, Unwin N, Bhopal R, White M, Watson B, Laker M, Alberti KG. Low levels of cardiovascular risk factors and coronary heart disease in a UK Chinese population. Journal of Epidemiology and Community Health. 1997;51:636-642
  41. 41. Nishimaru K, McHenry LC Jr, Toole JF. Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke. 1984 Jan-Feb;15(1):56-59

Written By

Mei-Ling Sharon Tai, Julia Sien Yuin Liew, Sheun Yu Mo and Mohamed Abdusalam Elwaifa

Submitted: 27 November 2017 Reviewed: 22 February 2018 Published: 17 October 2018